drug · small molecule
levosimendan
Phase 3updated 3mo agoby $TENX TENAX THERAPEUTICS, INC.🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for congestive heart failure and cardiovascular disease and 12 investigational indications.
targets
Phosphodiesterase 3Troponin, cardiac muscle
all catalysts(0)
nothing on the calendar yet
Trials studying levosimendan
News(1)
- STAT+: Heart failure drug from Tenax Therapeutics fails in pivotal studyA Tenax Therapeutics drug designed to treat a type of heart failure associated with high blood pressure in the lungs failed in a closely watched study.stat · 8d ago
Data sources
last refreshed 4m ago
Found something off?
comments(0)
5-min edit window · permanent after that